Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Martina Vaskova"'
Autor:
Zuzana Liba, Martina Vaskova, Josef Zamecnik, Jana Kayserova, Hana Nohejlova, Matyas Ebel, Jan Sanda, Gonzalo Alonso Ramos-Rivera, Klara Brozova, Petr Liby, Michal Tichy, Pavel Krsek
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Immune-mediated mechanisms substantially contribute to the Rasmussen encephalitis (RE) pathology, but for unknown reasons, immunotherapy is generally ineffective in patients who have already developed intractable epilepsy; overall
Externí odkaz:
https://doaj.org/article/448a32d261bc4f5194cf4292f001fb0d
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
Autor:
Marketa Zaliova, Jan Stuchly, Lucie Winkowska, Alena Musilova, Karel Fiser, Martina Slamova, Julia Starkova, Martina Vaskova, Ondrej Hrusak, Lucie Sramkova, Jan Stary, Jan Zuna, Jan Trka
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Novel biological subtypes and clinically important genetic aberrations (druggable lesions, prognostic factors) have been described in B-other acute lymphoblastic leukemia (ALL) during the last decade; however, due to a lack of studies on unselected c
Externí odkaz:
https://doaj.org/article/83a31a02ffa84184a5cd3db59a615b50
Autor:
Tomas Kalina, Petr Liby, Daniela Kuzilkova, Josef Zamecnik, Ales Vicha, Jan Stary, Michal Tichy, Martina Vaskova, Jan Hrabeta, Ondrej Hrusak
Publikováno v:
Journal of Neuro-Oncology. 143:15-25
The aim of this study was to test the possibility of using specimens obtained by a cavitron ultrasonic surgical aspirator (CUSA) in flow and mass cytometry investigations of pediatric brain tumors. CUSA specimens obtained from 19 pediatric patients w
Autor:
Matyas Ebel, Martina Vaskova, Jan Sanda, Petr Liby, Josef Zamecnik, Zuzana Liba, Gonzalo Alonso Ramos-Rivera, Hana Nohejlova, Pavel Krsek, Michal Tichy, Jana Kayserova, Klara Brozova
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Neurology
BMC Neurology
Background Immune-mediated mechanisms substantially contribute to the Rasmussen encephalitis (RE) pathology, but for unknown reasons, immunotherapy is generally ineffective in patients who have already developed intractable epilepsy; overall laborato
Autor:
David Šálek, Heidi Mocikova, Robert Pytlik, Martina Vaskova, Vít Procházka, Jan Trka, Marketa Kalinova, Roman Kodet, Andrea Janíková, Ester Mejstrikova, Kristina Forsterova, Pavel Klener, Eva Fronkova, Martin Simkovic, P. Blahovcova, David Belada, Marek Trneny
Publikováno v:
Hematological Oncology. 36:773-778
Rituximab maintenance (RM) prolongs survival of elderly patients with mantle cell lymphoma (MCL). Persistent minimal residual disease (MRD) after induction repeatedly correlated with shorter progression-free survival (PFS). However, none of the publi
Autor:
Jan Starý, Ondřej Hrušák, Ondřej Pelák, Martina Vaskova, Tomas Kalina, Herbert Stadler, Daniel Thurner, Kristian Stanar, Marie-Luise Kiene, Jan Stuchlý, Daniela Kužílková
Publikováno v:
Cytometry Part A. 91:62-72
In mass cytometry, the isolation of pure lymphocytes is very important to obtain reproducible results and to shorten the time spent on data acquisition. To prepare highly purified cell suspensions of peripheral blood lymphocytes for further analysis
Publikováno v:
Genes, Chromosomes and Cancer. 55:727-737
Acute lymphoblastic leukaemias (ALL) with 51-67 chromosomes are defined as high hyperdiploid (HHD) and are generally associated with good prognosis. However, several studies show heterogeneity in HHD ALL and suggest that the favourable prognosis is a
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
Autor:
Marketa, Zaliova, Jan, Stuchly, Lucie, Winkowska, Alena, Musilova, Karel, Fiser, Martina, Slamova, Julia, Starkova, Martina, Vaskova, Ondrej, Hrusak, Lucie, Sramkova, Jan, Stary, Jan, Zuna, Jan, Trka
Publikováno v:
Haematologica
Novel biological subtypes and clinically important genetic aberrations (druggable lesions, prognostic factors) have been described in B-other acute lymphoblastic leukemia (ALL) during the last decade; however, due to a lack of studies on unselected c
Autor:
L. Winkowska, Lucie Slamova, E. Mejstrikova, A. Musilova, O. Hrusak, B. Vakrmanova, Marketa Zaliova, A. Kolenovska, Tomas Kalina, Eva Fronkova, P. Svec, Michaela Novakova, J. Stary, J. Trka, Karel Fiser, M. Bruggemann, Martina Vaskova, M. Ritgen
Publikováno v:
HemaSphere. 3:40-41
Autor:
Adela Berkova, Andrea Janíková, Jan Trka, Heidi Mocikova, Jozef Kubinyi, Martina Vaskova, Marek Trneny, Martin Simkovic, Vít Procházka, Vit Campr, Marketa Kalinova, Radek Jaksa, Robert Pytlik, Pavel Klener, Jana Markova, Aleš Obr, P. Blahovcova, Kyra Michalova, Roman Kodet, David Belada, Ester Mejstrikova, Kristina Forsterova, Eva Fronkova, David Šálek
Publikováno v:
Hematological oncology. 36(1)
Implementation of cytarabine into induction therapy became standard of care for younger patients with mantle cell lymphoma (MCL). On the basis of its beneficial impact, many centers incorporated cytarabine at lower doses also into first-line treatmen